Close

MED Financial Facts

Revenue: 68.58M
Cost of sales: 16.42M
See Full Income Statement

Additional paid-in capital: 1.59M
Total liabilities: 28.53M
See Full Balance Sheet

Medifast Inc. (MED) Earnings

  |   Expand Research on MED
Next EPS Date 4/29/24 EPS Growth Rate -59.1%
Average EPS % Beat Rate +56.0% Revenue Growth Rate -41.0%
Average % Move 1-Wk after EPS -7.8% Normal Earnings Time After Close
Date  Qtr EPS Cons. Surprise Revs Cons. Gd. 1-Week % 1-Day % Details
3/31/11 Q410 $0.23$0.32 -$0.09$63M$64.67M = Details
5/9/11 Q111 $0.44$0.41 +$0.03$74.3M$73.91M N/A Details
8/4/11 Q211 $0.38$0.47 -$0.09$78.3M$81.83M N/A Details
11/3/11 Q311 $0.36$0.37 -$0.01$76.1M$78.89M N/A Details
3/13/12 Q411 $0.08$0.21 -$0.13$69M$70.97M = Details
5/8/12 Q112 $0.29$0.37 -$0.08$88.9M$85.75M N/A Details
11/5/12 Q312 $0.52$0.40 +$0.12$91M$89.97M = Details
3/7/13 Q412 $0.28$0.25 +$0.03$83.2M$82.9M = Details